âNeed a degree to get a pay rise â donât bother if youâre 61 or older!â
âWant to work beyond the age of 65 â afraid not, itâs in our Partnership Deed!â
These may sound like the worst job adverts in the world, but in fact they are the subject matter of two cases whose judgments were handed down by the Supreme Court last week (25 April 2012). These key cases are set to challenge employerâs attitude to age and retirement.
If you are a person who has a knack for convincing others to follow your lead and you have a special curiosity in the sciences, you could be the perfect candidate for a career in pharmaceutical sales. A positive, proactive attitude and a fierce determination to succeed are all important qualities in pharmaceutical sales.
If the world of pharmaceuticals is a fascinating one for you, particularly understanding the nature of medicines, metabolism and drug interactions, then a career in pharmacy may be a solid match for you.
Many employers will agree with David Cameron, that a decade of Health and Safety rules and regulations intended to protect people, have in fact simply overwhelmed businesses with extra red tape.
Recruiters are very busy people, and typically have little time to read and select CVs for any given role. For them itâs a filtering process, often starting with a pile of CVâs and throwing out the bad ones before reading in more detail, the ones that are left. Therefore your task is NOT to get thrown out with the bathwater, and ensure that your CV is one of the ones that makes it past the first cull!
It is estimated that long term sickness absence costs the UK economy almost ÂŁ9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.
New data on UCBâs anti-TNF biologic certolizumab pegol (Cimzia), disclosed this week in several poster presentations during the annual meeting of the American College of Rheumatology (ACR), show the treatment works well in rheumatoid arthritis (RA) patients irrespective of prior exposure to other biologics, and that results are sustained over 28 weeks.
Olwen Glynn Owen - Pharmiweb Field Reporter
Weâre seeing increasing demand for pharma marketing solutions to be based on the iPad, and itâs not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to be increasing. But whatâs interesting is that remote âself-serviceâ edetailing does not seem to be growing at the same rate. The predicted disintermediation of the traditional field sales model hasnât happened.
New drug formulations, biological agents, combination therapies and the latest pharmaceutical developments designed to improve outcomes in patients with a wide range of cancers were highlighted at EMCC 2001. Here are just a few of the highlights:
For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary.
Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the shape of the state has already changed.
Max Golby - PharmiWeb Field Reporter
At a moment when the national discourse on international aid is grounded in pessimism, David Cameronâs pledge to commit ÂŁ814m to help vaccinate the worldâs poorest children provides an necessary reminder of what international aid really can achieve.
Certolizumab pegol (Cimzia Âź) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC trial presented at the European League Against Rheumatism (EULAR) meeting in London, May 25-28 (abstract FRI021).
After six months of sometimes lively pursuit, the French pharmaceutical group, Sanofi-aventis, has agreed a deal to pay $20.1bn in cash for U.S. biotech firm Genzyme Corp after Sanofi made an increased offer of $74 per share.
Max Golby - PharmiWeb Field Reporter
If you are new to using PharmiWeb.com to find a new job, you'll soon realise that we have thousands of jobs listed and that they change every day. This means you may initially find the task a bit daunting.
However, itâs not really that hard, and with a bit of thought, you will soon be asking why you didnât do it years ago.
We have a fundamental problem with our health service. It's bloated, it's weighed down in bureaucracy and it's terribly inefficient. That's if you believe the diagnosis of our health service by the new Health Secretary, Andrew Lansley.
Economic uncertainty has fueled a growing trend toward self-employment and entrepreneurialism with one-in-five respondents worldwide now working outside the traditional employment relationship, and 50 percent saying that they would like to do so, according to the latest survey results from workforce solutions leader Kelly ServicesÂź.
RSS is a much under-estimated and under-used thing. It was originally conceived as an easy way of syndicating website content, hence the name âReally Simple Syndicationâ, but it now become a standard by which content is made available across the web to other sites or users.
Washington is famous for its lobbyists. Make no mistake, of all the industries currently making themselves heard on Capitol Hill, the healthcare lobby is one of the largest and the loudest. Indeed, according to the Center for Responsive Politics, the pharmaceutical industry had almost 1700 registered lobbyists in Washington as of late 2009. Unsurprisingly, then, the pharmaceutical industry has a considerable degree of pull on The Hill.
âYou really need some more experienceâ. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role in an industry.
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her